Fulgent Genetics, Inc. provided earning guidance for second quarter of 2022. For the second quarter of 2022, the company expects Total Revenue of approximately $125 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.77 USD | -0.48% | -3.93% | -28.16% |
05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.16% | 622M | |
-24.06% | 7.68B | |
+67.56% | 4.31B | |
+7.49% | 2.63B | |
-2.45% | 2.66B | |
-47.56% | 2.11B | |
-17.86% | 1.7B | |
-19.62% | 1.5B | |
+12.59% | 1.16B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earning Guidance for Second Quarter of 2022